Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Infectious Diseases Trend Monitor: South Korea South Korea will continue to invest in its laboratories to… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Infectious Diseases Trend Monitor: Japan Infectious disease testing is highly accessible in Japan.… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Medtech 2022/2023: seeking sustainable growth Global healthcare spending growth in 2022 has slowed despite… In-vitro diagnostics | Surgical device | Global | IVD Gateway | Surgical Gateway
Going global: opportunities for Chinese IVD companies Opportunistic growth opportunities from covid-19 have helped… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa
Supporting the global launch of a clinical chemistry assay One of the largest IVD multinational companies plans to… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Global | Centralised Diagnostics (CEDx) | IVD Gateway
APACのMedtech市場における動向を知る Take this opportunity to meet other industry leaders whilst… In-vitro diagnostics | Surgical device | Asia
How Vision 2030 is driving growth in Saudi Arabia’s IVD market The incidence of cardiovascular diseases (CVD) in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Middle East IVD market to recover to pre-pandemic growth rates from 2024 The Middle East IVD market has mostly recovered to… Centralised Diagnostics (CEDx) | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
Cardiac biomarker testing market outlook in Latin America The incidence of cardiovascular diseases (CVD) in… In-vitro diagnostics | Point-of-care testing (POCT) | Americas | IVD Gateway | Point-of-care testing (POCT)
The future of point-of-care cardiac biomarker testing With longer life expectancies in APAC, there is an… In-vitro diagnostics | Point-of-care testing (POCT) | Global | IVD Gateway | Point-of-care testing (POCT) | The Gateway
Cardiac biomarker testing market outlook in Asia-Pacific The incidence of cardiovascular diseases (CVD) in… In-vitro diagnostics | Point-of-care testing (POCT) | Asia | IVD Gateway | Point-of-care testing (POCT)
Cancer biomarker testing to grow in Asia The cancer burden in Asia is increasing, with new cancer… Cancer diagnostics | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Size and Share Plus | The Gateway
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now